152 related articles for article (PubMed ID: 13938756)
1. [On 2 family lines with Wilson's pseudosclerosis. Clinical course and therapy, with special reference to combined therapy with BAL, penicillamine and vitamin E].
NISHI N; IIZUKA R; FUJII H; KAWAMURA K; TAKAHATA N
No To Shinkei; 1963 Jan; 15():37-48. PubMed ID: 13938756
[No Abstract] [Full Text] [Related]
2. WILSON'S DISEASE, AN INBORN ERROR OF METABOLISM AND A MODEL OF DEGENERATIVE CENTRAL NERVOUS SYSTEM DISEASE.
RAVIN HA
Bull Sinai Hosp Detroit; 1964; 12():25-30. PubMed ID: 14156393
[No Abstract] [Full Text] [Related]
3. CHEMICAL THERAPY OF WILSON'S DISEASE.
GOLDSTEIN NP; RANDALL RV; GROSS JB
J Indian Med Prof; 1965 Jul; 12():5399-402. PubMed ID: 14339732
[No Abstract] [Full Text] [Related]
4. [OUR EXPERIENCE IN THE TREATMENT OF WILSON'S DISEASE WITH PENICILLAMINE].
BOUDIN G; PEPIN B; LAURAS A; BARRAINE R
Rev Neurol (Paris); 1963 Jul; 109():82-6. PubMed ID: 14091678
[No Abstract] [Full Text] [Related]
5. [MODE OF ACTION OF CHELATOR AGENTS IN THE TREATMENT OF HEPATOLENTICULAR DEGENERATION].
OZKAN E; PRIFTI J; TAG T; AKSOY M; EKMEKCI A
Turk Tip Cemiy Mecm; 1964 Sep; 30():612-20. PubMed ID: 14224682
[No Abstract] [Full Text] [Related]
6. Effects of penicillamine and dimercaprol on turnover of copper in patients with Wilson's disease.
OSBORN SB; WALSHE JM
Lancet; 1958 Jan; 1(7011):70-3. PubMed ID: 13503211
[No Abstract] [Full Text] [Related]
7. Penicillamine, a new oral therapy for Wilson's disease.
WALSHE JM
Am J Med; 1956 Oct; 21(4):487-95. PubMed ID: 13362281
[No Abstract] [Full Text] [Related]
8. [WILSON'S DISEASE].
WATANABE H
Naika; 1965 Mar; 15():435-8. PubMed ID: 14323829
[No Abstract] [Full Text] [Related]
9. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
[No Abstract] [Full Text] [Related]
10. [CURRENT ASPECTS OF WILSON'S DISEASE].
PETIT H
Lille Med; 1964 Oct; 9():750-8. PubMed ID: 14210920
[No Abstract] [Full Text] [Related]
11. WILSON'S DISEASE.
BUMBALO TS; STAUB RU; VILLANUEVA OQ
GP; 1964 Jun; 29():89-93. PubMed ID: 14143829
[No Abstract] [Full Text] [Related]
12. WILSON'S DISEASE AS A GASTROENTEROLOGIC PROBLEM.
STERNLIEB I
Am J Gastroenterol; 1964 Sep; 42():264-70. PubMed ID: 14202497
[No Abstract] [Full Text] [Related]
13. Surviving Wilson's disease.
Yonetani L; Walshe JM
Clin Med (Lond); 2001; 1(1):72-4. PubMed ID: 11358083
[No Abstract] [Full Text] [Related]
14. HEPATO-LENTICULAR DEGENERATION (WILSON'S DISEASE) TREATED BY PENICILLAMINE.
RICHMOND J; ROSENOER VM; TOMPSETT SL; DRAPER I; SIMPSON JA
Brain; 1964 Dec; 87():619-38. PubMed ID: 14236007
[No Abstract] [Full Text] [Related]
15. [Treatment of Wilson's disease with penicillamine and guajacuran].
BLEHOVA B; HEYROVSKY A; NEBUDOVA J; VOTAVA Z
Cesk Neurol; 1963 Jan; 26():45-9. PubMed ID: 13971614
[No Abstract] [Full Text] [Related]
16. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
[TBL] [Abstract][Full Text] [Related]
17. [Ocular manifestations of Wilson's disease treated by penicillamine].
MICHIELS J; LATERRE C; DUMOULIN D
Bull Soc Belge Ophtalmol; 1963; 132():552-61. PubMed ID: 13935542
[No Abstract] [Full Text] [Related]
18. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
[TBL] [Abstract][Full Text] [Related]
19. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).
DENNY-BROWN D; PORTER H
Trans Am Neurol Assoc; 1951; 56():79-84. PubMed ID: 14913592
[No Abstract] [Full Text] [Related]
20. The effect of BAL (2,3-dimercaptopropanol) on hepatolenticular degeneration (Wilson's disease).
DENNY-BROWN D; PORTER H
N Engl J Med; 1951 Dec; 245(24):917-25. PubMed ID: 14882450
[No Abstract] [Full Text] [Related]
[Next] [New Search]
